Skip to content

Depression: all studies

Page 872 of 1,040: studies 8,711 to 8,720 of 10,391, newest first. Back to the depression overview

Research

Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans

The Journal of Alternative and Complementary Medicine August 30, 2018 Kaitlin A. Harding, Tracy L. Simpson, David J. Kearney 19 citations

Objectives: Post-traumatic stress disorder (PTSD) and irritable bowel syndrome (IBS) are highly comorbid conditions associated with reduced health-related quality of life. Comorbid prevalence is especially high among veterans, ranging from 23% to 51%, but there is limited research on integrative treatments. Design: To improve treatment of comorbid PTSD and IBS, this study examined the impact of...

Feasibility of Formal Mindfulness-Based Stress-Resilience Training Among Surgery Interns

JAMA Surgery August 30, 2018 Carter C Lebares, Amy Hershberger, Ekaterina V. Guvva et al. 135 citations

Importance: Among surgical trainees, burnout and distress are prevalent, but mindfulness has been shown to decrease the risk of depression, suicidal ideation, burnout, and overwhelming stress. In other high-stress populations, formal mindfulness training has been shown to improve mental health, yet this approach has not been tried in surgery. Objective: To test the feasibility and acceptability...

Applying ketamine to alleviate the PTSD-like effects by regulating the HCN1-related BDNF.

Progress in Neuro-Psychopharmacology and Biological Psychiatry August 30, 2018 Lanwei Hou, Yirui Qi, Hongwei Sun et al.

Post-traumatic stress disorder (PTSD) is commonly associated with concurrent anxiety and depression symptoms, and reduce the expression of the Brain-Derived Neurotrophic Factor (BDNF) which promotes the proliferation and survival of neurons. The hyperpolarization-activated cyclic nucleotide-gated channel 1(HCN1) could be inhibited by the ketamine, a drug to alleviate depression and anxiety, and...

Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial.

Trials August 29, 2018 Yang Zhou, Yuming Peng, Jinghan Fang et al.

Perioperative depressive symptoms (PDS) are common mental comorbidities that influence clinical outcomes and prognosis. However, there is no rapid-acting treatment to address these symptoms during a limited hospital stay. This is a single-center, randomized, placebo-controlled, and double-blind trial. Randomization will be applied and stratified by the severity of PDS (moderate versus severe)....

DOI: 10.1186/s13063-018-2831-0 (opens in new tab) Full text (opens in new tab) Ketamine Depression symptom Perioperative Randomized controlled trial

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

American Journal of Psychiatry August 29, 2018 Nolan Williams, Boris D. Heifets, Christine Blasey et al. 510 citations

OBJECTIVE: In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine whether opioid receptor antagonism prior to administration of intravenous ketamine attenuates its acute antidepressant or dissociative effects. METHOD: In a proposed double-blind crossover study of 30 adults with treatment-resistant...

DOI: 10.1176/appi.ajp.2018.18020138 (opens in new tab) Ketamine Antagonism Antidepressant Pharmacology +2

Anapanasati: (mindfulness of breathing) an access to insight.

National Journal of Research in Ayurved Science August 23, 2018 Mahesh Kashiram Talekar, Rajesh S Kolarkar

Depression let’s talk- WHO is leading a one-year global campaign on depression. Depression comes under psychiatric disorders. According to WHO healthy person definition is health is complete state of physical, mental and social well-being and not merely the absence of disease or infirmity. Vipassana meditation technique is very useful for balancing of mind. Ānāpānasati breathing technique...

Syntheses of Ketamine and Related Analogues: A Mini Review

Synthesis August 20, 2018 I. Dimitrov, W. Denny, Jiney Jose

Abstract Ketamine [2-(2-chlorophenyl)-2-(methylamino)cyclohexanone] is a dissociative anaesthetic, first developed in 1963 by Parke-Davis. It finds widespread application in the treatment of battlefield injuries, and in emergency departments for use in children. In recent times the clinical interest in ketamine has increased due to the positive impact it has in treating depression and the rapid...

Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).

Translational Behavioral Medicine August 20, 2018 Jong Y Park, Cecile A Lengacher, R. Reich et al.

Genetic variations of breast cancer survivors (BCS) may contribute to level of residual symptoms, such as depression, stress, fatigue, and cognitive impairment. The objective of this study was to investigate whether particular single-nucleotide polymorphisms (SNPs) moderated symptom improvement resulting from the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR[BC]) program. An...

Benefits of Mindfulness for Parenting in Mothers of Preschoolers in Chile

Frontiers in Psychology August 17, 2018 Carolina Corthorn 37 citations

The present study evaluated whether mothers’ participation in a mindfulness-based intervention led to statistically significant differences in their general levels of stress, depression, anxiety, parental stress, mindful parenting and mindfulness. Forty-three mothers of preschool-age children participated, 21 in the intervention group and 22 in the comparison group. Scores of mental health...

Prolongation of REM Sleep Latency in Nightmare Disorder May Indicate Subtle REM Sleep Fragmentation and Decreased REM Sleep Propensity

Journal of Clinical Sleep Medicine August 15, 2018 M. Gupta, D. Pur

Journal of Clinical Sleep Medicine, Vol. 14, No. 8 August 15, 2018 Creamer and colleagues1 have addressed the very important topic of the high prevalence of clinically significant nightmares (31.2% of 473 military personnel met criteria for nightmare disorder [NDO] and endorsed trouble falling asleep because of bad dreams on at least a weekly basis) among military personnel, with possibly only...